Shenzhen YHLO Biotech Co., Ltd. Share Price

Equities

688575

CNE100005204

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 23:00:00 23/06/2024 BST 5-day change 1st Jan Change
23.58 CNY -1.30% Intraday chart for Shenzhen YHLO Biotech Co., Ltd. +3.69% +3.10%

Financials

Sales 2024 * 2.27B 312M 24.65B Sales 2025 * 2.81B 387M 30.54B Capitalization 13.42B 1.85B 146B
Net income 2024 * 481M 66.27M 5.23B Net income 2025 * 644M 88.73M 7B EV / Sales 2024 * 5.92 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 4.78 x
P/E ratio 2024 *
27.9 x
P/E ratio 2025 *
20.8 x
Employees 1,759
Yield 2024 *
-
Yield 2025 *
-
Free-Float 38.11%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.30%
1 week+3.69%
Current month-2.92%
1 month+1.90%
3 months-4.84%
6 months+4.20%
Current year+3.10%
More quotes
1 week
23.38
Extreme 23.38
24.66
1 month
22.61
Extreme 22.61
26.10
Current year
19.91
Extreme 19.91
26.60
1 year
15.31
Extreme 15.31
26.60
3 years
15.31
Extreme 15.31
37.42
5 years
15.31
Extreme 15.31
52.71
10 years
15.31
Extreme 15.31
52.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 40 31/12/09
Chairman 46 30/11/12
Chairman 33 30/11/12
Members of the board TitleAgeSince
Director/Board Member 54 09/10/23
Chairman 33 30/11/12
Chief Executive Officer 40 31/12/09
More insiders
Date Price Change Volume
24/06/24 23.58 -1.30% 2,099,713
21/06/24 23.89 -1.04% 1,884,830
20/06/24 24.14 +2.29% 4,191,559
19/06/24 23.6 -0.38% 4,192,512
18/06/24 23.69 +0.17% 3,839,573

End-of-day quote Shanghai S.E., June 23, 2024

More quotes
Shenzhen YHLO Biotech Co Ltd is a China-based company principally engaged in the research and development, manufacture and sales of in-vitro diagnostic equipment and supporting reagents, as well as the agency sales of some non-self-produced medical device products. The Company's products are applied in autoimmunity, reproductive health, diabetes and infectious disease fields. The Company's main products include in-vitro diagnostic instruments and supporting reagents based on chemiluminescence, immunoblotting, enzyme-linked immunoassay, immunofluorescence chromatography and other methodologies. The Company distributes its products in domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
23.58 CNY
Average target price
30.22 CNY
Spread / Average Target
+28.17%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688575 Stock